Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

Thank you, and welcome, everyone, to our fourth quarter and full year 2025 earnings call. Joining me on today's call are Dr. Mark Goldsmith, our Chairman and Chief Executive Officer; and Jack Anders, ...

Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...

Introduction Tungiasis is a highly neglected tropical disease of the skin caused by an embedded female sand flea affecting ...

A new study suggests that lenders may get their strongest overall read on credit default risk by combining several machine learning models rather than relying on a single algorithm. The researchers ...

Every day, millions of people input prompts (whether questions or instructions) into AI tools such as ChatGPT, Perplexity, Claude, DALL-E, or Meta AI. Recently, media coverage highlighted what seemed ...

CEO Mark Goldsmith outlined the company’s late-stage plans for its RAS(ON) inhibitor daraxonrasib, discussed expansion into ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals—a discovery that could accelerate and improve how medicines ...

Industrial applications require high transmission rates, more bandwidth and ways to integrate motion control with other applications. CAN open language enables plug ...

The post-cesarean maternal mortality rate remains high, reflecting challenges in obstetric care. In the Dassa-Glazoué health ...